Even as US drug shortages hit a decade-high of 323 drugs across 22 therapies in the JanuaryMarch quarter of calendar year 2024 (CY24), analysts feel this presents an opportunity for Indian pharmaceutical (pharma) exporters.
US active drug shortages have further increased, after stabilising at 300-310 drugs in calendar year 2023, to 323 drugs in the first quarter (Q1) of CY24, according to American Society of Health-System Pharmacists data, said IIFL Securities.
While analysts were not able to give market size estimates of these 323 drugs spread across categories like anti-infectives, hormones, oncology, etc., overall exports to the US have already risen sharply in 2023-24 (FY24).
Udaya Bhaskar, director-general of the Pharmaceutical Export Promotion Council of India (Pharmexcil), told Business Standard that shortages helped Indian pharma exports to grow not only in the US but also contributed to overall growth.
"We exported $8.72 billion with 15.6 per cent growth. Total pharma exports from India grew by 9.6 per cent to $27.8 billion." India Ratings and Research (Ind-Ra) analysts feel that this will not only provide the potential for volume growth but also limit price erosion to single digits over the next 12-18 months, leading to improved returns.
Esta historia es de la edición May 28, 2024 de Business Standard.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor ? Conectar
Esta historia es de la edición May 28, 2024 de Business Standard.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor? Conectar
Women in a shadow war
In the 21st century, many countries have started admitting women into the military in combat roles as fighter pilots and frontline soldiers in grudging recognition of their capabilities and courage.
NCPA-Soho 1st theatrical tie-up blurs boundaries
Indian 'drag kings' to take stage in Mumbai, London in Gentlemen's Club
GAINS AT PUMPS SUPERNORMAL
But low cracks, or profits from processing crude oil into petrol & diesel, have contributed to abysmal refining margins, prompting rethink on lowering retail fuel prices
Everybody wants a 'piece' on Dwarka Expressway
Dwarka Expressway, a 29.1-kilometre (km)-long 16-lane stretch between Shiv Murti in Delhi and Kherki Daula in Gurugram, has become a real estate hotspot, attracting top developers from all over the country announcing their projects in the area.
Accumulate gold through SIP if portfolio allocation below 10%
Gold, which closed at ₹75,447 per 10 gram in the domestic market on Friday (and is trading at ₹2,689.6 per ounce on the Comex), is up 29.4 per cent over the past year.
IT aims for sky after Accenture's Q4 results
Nifty IT index ends 0.4% higher over previous close
NSE, BSE revise transaction fee
Stock exchanges National Stock Exchange (NSE) and BSE on Friday revised their charges for various segments in the market — to align them with the true-to-label circular by the Securities and Exchange Board of India (Sebi) which mandates uniform fee irrespective of the turnover.
GQG Partners settles charges with US SEC
Boutique investment firm GQG Partners has settled charges of potential violations of whistleblower rules with the Securities and Exchange Commission (SEC) — the regulatory body in the United States — by paying a $500,000 penalty.
Sebi plans mandatory disclosures for direct plan MF schemes
The Securities and Exchange Board of India (Sebi) has proposed to make it mandatory for mutual fund houses to give separate disclosures for direct plan and regular plan schemes in their half-yearly financial results.
Crompton Greaves Consumer may underperform on demand concerns
The stock of Crompton Greaves Consumer Electricals has shed about 12 per cent since the start of the month due to a muted near-term outlook.
